Pharma News

Sun Pharma offers to buy remaining Taro shares

Home/Pharma News | Posted 10/11/2011

Taro Pharmaceutical Industries confirmed that it had received a letter on 19 October 2011 from Sun Pharma offering to buy all outstanding shares of Taro, not currently held by Sun Pharma, at a price of US$24.50 per share.

Pfizer invests Euros 145 million in Irish biotech site

Home/Pharma News | Posted 28/10/2011

Pfizer, the world’s leading pharmaceutical company, is to make a substantial investment of Euros 145 million at its Grange Castle biotechnology manufacturing facility in Clondalkin, Dublin, Ireland, it was revealed 22 September 2011.

Drawing score lines on pills to delay generics

Home/Pharma News | Posted 28/10/2011

Brand-name drugmakers have come up with numerous ways in the past to delay generics from entering the market. These can include making slight changes to the doses, introducing a paediatric form, pay-for-delay deals or even buying the company that makes the active pharmaceutical ingredient. The latest novel tactic from an originator drug company, however, is coming simply in the form of a line.

Aurobindo forms generics joint venture with Russia’s Diod

Home/Pharma News | Posted 21/10/2011

India-based Aurobindo Pharma (Aurobindo) announced on 7 September 2011 that it had formed a joint venture with Russian company Ojsc Diod (Diod) to manufacture and sell pharmaceutical products in Belarus, Kazakhstan and Russia.

Pfizer and US pharmacies fight counterfeit medicines

Home/Pharma News | Posted 07/10/2011

Pfizer and the US National Association of Boards of Pharmacy (NABP) announced on 29 September 2011 that they have launched a new effort to draw attention to the risks associated with counterfeit drugs and to help patients learn how to buy medicines online safely.

Sun Pharma’s US operations partially on track

Home/Pharma News | Posted 07/10/2011

Sun Pharma announced on 19 September 2011 that its US arm has resolved issues raised by the country’s health regulator regarding violation of manufacturing standards.

Authorised generics implicated in pay-to-delay deals

Home/Pharma News | Posted 30/09/2011

A US Federal Trade Commission (FTC) report has found that authorised generics may reduce generics competition. The report also shows that some originator companies may have used agreements not to launch an authorised generic drug as a way to compensate would-be generic competitors for delaying entry into the market.

Eli Lilly in deal with Turkish generics company

Home/Pharma News | Posted 09/09/2011

American drugmaker Eli Lilly is in talks to form a partnership with, and potentially invest in, Turkish generic drugs company Mustafa Nevzat İlaç Sanayii A.Ş. (MN Pharmaceuticals), according to a Wall Street Journal report from 2 September 2011.

Medivir subsidiary BioPhausia sells generics business

Home/Pharma News | Posted 02/09/2011

Sweden-based Medivir announced on 25 August 2011 that its subsidiary BioPhausia had reached an agreement to sell its generics business (BMM Pharma) to Bluefish Pharmaceuticals (Bluefish) for SEK 26 million plus the value of inventories, some SEK 12 million. The staff of BMM Pharma will not be transferred in the acquisition.

GaBI Online launches its country focus section

Home/Pharma News | Posted 02/09/2011

- Provides Easy to Find Country Specific Information -

FIRST IN THE SPOTLIGHT – BELGIUM, THE NETHERLANDS AND UK